New combo aims to control advanced breast cancer
NCT ID NCT07427394
First seen Feb 28, 2026 · Last updated May 10, 2026 · Updated 6 times
Summary
This study tests two experimental drugs, camizestrant and atirmociclib, taken together by people with a certain type of advanced breast cancer (ER-positive, HER2-negative) that has worsened after previous treatment. The main goal is to check the safety of the combination and see how the body processes the drugs. About 24 participants will be enrolled, and the study is not yet recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
St Louis, Missouri, 63108, United States
-
Research Site
East Providence, Rhode Island, 02915, United States
-
Research Site
Nashville, Tennessee, 37203, United States
-
Research Site
Cambridge, CB2 0QQ, United Kingdom
-
Research Site
London, EC1M6BQ, United Kingdom
-
Research Site
Manchester, M20 4GJ, United Kingdom
Conditions
Explore the condition pages connected to this study.